Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Inocras Inc.
Accent Therapeutics to Utilize Inocras’ CancerVision™ and MRDVision™ Platforms in Phase 1/2 ATX-295 Clinical Study
Today 9:00 EST
From
Inocras Inc.
Via
Business Wire
Inocras, Samsung Medical Center and Seoul St. Mary’s Hospital Researchers Publish Groundbreaking Study with 1,364 Whole-Genomes of Breast Cancer in Nature
December 03, 2025
From
Inocras Inc.
Via
Business Wire
Inocras Expands WGS-Based Cancer Precision Diagnostics CancerVision™ to 10 Hospitals
July 15, 2025
From
Inocras Inc.
Via
Business Wire
ChiMei Medical Center adopts Inocras MRDVision and WGS bioinformatics platform for precision oncology in Taiwan
July 07, 2025
From
Inocras Inc.
Via
Business Wire
Inocras and Center for Data Driven Discovery in Biomedicine Enter Collaborative Research Agreement to Advance Sinonasal Cancer Research
April 21, 2025
From
Inocras Inc.
Via
Business Wire
Inocras earns ISO 15189 accreditation from ANSI ASQ National Accreditation Board (ANAB)
December 10, 2024
From
Inocras Inc.
Via
Business Wire
Inocras and Summit Pharmaceuticals International Corporation Announce Collaboration Aim to Transform Clinical Genomics in Japan
November 05, 2024
From
Inocras Inc.
Via
Business Wire
Whole Genome MRD Detection with One-in-a-Million LOD: Inocras Launches WGS-Based, Panel-Free MRDVision, Leveraging Ultima ppmSeqTM Technology
October 31, 2024
From
Inocras Inc.
Via
Business Wire
Inocras Unveils Breakthrough Study, Proving Target-Enhanced Whole-Genome Sequencing (TE-WGS) Outperforms Standard Panel Sequencing
October 09, 2024
From
Inocras Inc.
Via
Business Wire
Inocras to Offer High Quality and Cost-Effective Whole Genome Sequencing and Bioinformatics Services on Ultima UG 100TM platform
August 14, 2024
From
Inocras Inc.
Via
Business Wire
Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching
June 03, 2024
From
Inocras Inc.
Via
Business Wire
Inocras Presents Poster for Breast Cancer at 2024 ASCO Annual Meeting, Showing Transformative Impact of WGS-based HRD Testing
May 31, 2024
From
Inocras Inc.
Via
Business Wire
Inocras and IMBdx Announce Strategic Partnership to Transform Cancer Patient Care in the U.S.
May 22, 2024
From
Inocras Inc.
Via
Business Wire
Inocras Pioneers Precision Health with Revolutionary Whole Genome Insights
April 25, 2024
From
Inocras Inc.
Via
Business Wire
Inocras to Present Enhancing Genomic Analysis in Cancer Diagnostics at the 2024 AACR Annual Meeting
April 05, 2024
From
Inocras Inc.
Via
Business Wire
Inocras Inc. Unveils Rebranding of Genome Insight
March 18, 2024
From
Inocras Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit